enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Esophageal candidiasis - Wikipedia

   en.wikipedia.org/wiki/Esophageal_candidiasis

   Treatment should continue for 14 days after relief of symptoms. Other therapy options include: Nystatin is an effective treatment for mild esophageal candidiasis. [2] It can be used as (swish, do not swallow) treatment for oral candidiasis that occurs with the use of asthma pumps.

3. Nystatin - Wikipedia

   en.wikipedia.org/wiki/Nystatin

   Nystatin, sold under the brand name Mycostatin among others, is an antifungal medication. [1] It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal candidiasis, and vaginal yeast infections. [1] It may also be used to prevent candidiasis in those who are at high risk. [1]

4. Fluconazole - Wikipedia

   en.wikipedia.org/wiki/Fluconazole

   The treatment of non-systemic Candida infections of the vagina ("yeast infections"), throat, and mouth. Certain systemic Candida infections in people with healthy immune systems, including infections of the bloodstream, kidney, or joints. Other antifungals are usually preferred when the infection is in the heart or central nervous system, and ...

5. Takeda's treatment becomes first oral therapy for esophageal ...

   www.aol.com/news/us-fda-approves-takedas-therapy...

   Takeda's treatment will be available in stick packs of 2 milligram doses by the end of February, the company said. The company has set wholesale acquisition cost for the therapy, given twice daily ...

6. Micafungin - Wikipedia

   en.wikipedia.org/wiki/Micafungin

   Micafungin is indicated for the treatment of candidemia, acute disseminated candidiasis, Candida peritonitis, abscesses and esophageal candidiasis.. Micafungin works by way of concentration-dependent inhibition of 1,3-beta-D-glucan synthase resulting in reduced formation of 1,3-beta-D-glucan, which is an essential polysaccharide comprising one-third of the majority of Candida spp. cell walls.

7. US FDA approves BeiGene's esophageal cancer therapy - AOL

   www.aol.com/news/us-fda-approves-beigenes...

   The therapy, branded as Tevimbra, was approved as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carcinoma. The American Cancer Society estimates there ...